Germany Legal Cannabis Market Size, Share & Trends Analysis Report By Source (Hemp, Marijuana), By Derivatives (CBD, THC, Others), By End Use, And Segment Forecasts, Key Companies And Competitive Analysis, 2025 - 2030
This report can be delivered to the clients within 2 Business Days
Germany Legal Cannabis Market Growth & Trends
The Germany legal cannabis market size is estimated to reach USD 85.64 million by 2030, registering to grow at a CAGR of 14.09% from 2025 to 2030 according to a new report by Grand View Research, Inc. Factors such as rising social acceptance of cannabis, growing medical applications of cannabis, increasing R&D & technological innovation, and the introduction of new cultivation technologies are expected to drive the cannabis industry in the country. For instance, in February 2024, according to data published in Reuters, 4.5 million individuals are estimated to use cannabis in Germany.
Furthermore, favorable government initiatives and reimbursement policies fuel the market growth. For instance, according to data published by the Federal Union of German Associations of Pharmacists (ABDA), the number of prescriptions for medical cannabis for Statutory Health Insurance (SHI)-insured patients in Germany was 338,500 in 2022. Furthermore, according to the same source, 14,840 Kg of cannabis was delivered to pharmacies for medicinal purposes in 2022.
Moreover, growing awareness among people regarding the therapeutic applications of cannabis and the launch of online cannabis prescription platforms drive market growth. For instance, in September 2023, Cantourage Group SE, a Berlin-based company, introduced Telecan, a telemedicine platform for medical cannabis, under the guidance of Florian Wesemann, a medical doctor. The platform offers a simple and convenient way for potential patients to access cannabis therapy.
In recent years, there has been a significant rise in the usage of cannabis and its derivatives in Germany. The medical application of CBD has gained immense popularity, leading to the development of policies for its distribution and use by the government. Moreover, conferences and various events being organized for cannabis industry leaders drive market growth. For instance, the International Cannabis Business Conference was to be held in Berlin in April 2024, Germany’s biggest annual gathering of influential political and cannabis business leaders.
The cannabis industry has witnessed the development of new techniques and technologies that aid in its cultivation, and these advancements are expected to boost market growth. The demand for technologically advanced cannabis production has led to the optimization of resources by cultivators. This, coupled with the increased utilization of hemp and marijuana in various sectors, such as personal care & cosmetics, pharmaceuticals, nutraceuticals, and food, & beverages, has impelled market growth. In addition, the use of cannabis and its derivatives by various businesses as a raw material for manufacturing products is projected to drive market growth over the forecast period.
Germany Legal Cannabis Market Report Highlights
The Cronos Group
Organigram Holding, Inc
Tilray Brands
Canopy Growth Corporation
Aurora Cannabis
SynBiotic
Cansativa GmbH
DEMECAN
Four 20 Pharma
Avextra Pharma GmbH
Germany Legal Cannabis Market Growth & Trends
The Germany legal cannabis market size is estimated to reach USD 85.64 million by 2030, registering to grow at a CAGR of 14.09% from 2025 to 2030 according to a new report by Grand View Research, Inc. Factors such as rising social acceptance of cannabis, growing medical applications of cannabis, increasing R&D & technological innovation, and the introduction of new cultivation technologies are expected to drive the cannabis industry in the country. For instance, in February 2024, according to data published in Reuters, 4.5 million individuals are estimated to use cannabis in Germany.
Furthermore, favorable government initiatives and reimbursement policies fuel the market growth. For instance, according to data published by the Federal Union of German Associations of Pharmacists (ABDA), the number of prescriptions for medical cannabis for Statutory Health Insurance (SHI)-insured patients in Germany was 338,500 in 2022. Furthermore, according to the same source, 14,840 Kg of cannabis was delivered to pharmacies for medicinal purposes in 2022.
Moreover, growing awareness among people regarding the therapeutic applications of cannabis and the launch of online cannabis prescription platforms drive market growth. For instance, in September 2023, Cantourage Group SE, a Berlin-based company, introduced Telecan, a telemedicine platform for medical cannabis, under the guidance of Florian Wesemann, a medical doctor. The platform offers a simple and convenient way for potential patients to access cannabis therapy.
In recent years, there has been a significant rise in the usage of cannabis and its derivatives in Germany. The medical application of CBD has gained immense popularity, leading to the development of policies for its distribution and use by the government. Moreover, conferences and various events being organized for cannabis industry leaders drive market growth. For instance, the International Cannabis Business Conference was to be held in Berlin in April 2024, Germany’s biggest annual gathering of influential political and cannabis business leaders.
The cannabis industry has witnessed the development of new techniques and technologies that aid in its cultivation, and these advancements are expected to boost market growth. The demand for technologically advanced cannabis production has led to the optimization of resources by cultivators. This, coupled with the increased utilization of hemp and marijuana in various sectors, such as personal care & cosmetics, pharmaceuticals, nutraceuticals, and food, & beverages, has impelled market growth. In addition, the use of cannabis and its derivatives by various businesses as a raw material for manufacturing products is projected to drive market growth over the forecast period.
Germany Legal Cannabis Market Report Highlights
- By source, the hemp segment dominated the market with the highest revenue share of 84.50% in 2024. Hemp covers an extensive range of products, including supplements, nutritional powders, beverages, protein & nutrition bars, animal feed, and pet food.
- By derivatives, the CBD segment dominated the market with the largest revenue share of 63.61% in 2024. CBD is the non-psychoactive compound found in the cannabis plant, and its adoption is increasing for a wide range of health benefits.
- By end use, the industrial use segment dominated the market with a revenue share of 80.26% in 2024.
The Cronos Group
Organigram Holding, Inc
Tilray Brands
Canopy Growth Corporation
Aurora Cannabis
SynBiotic
Cansativa GmbH
DEMECAN
Four 20 Pharma
Avextra Pharma GmbH
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Source outlook
2.2.2. Derivatives outlook
2.2.3. End Use outlook
2.3. Competitive Insights
CHAPTER 3. GERMANY LEGAL CANNABIS MARKET VARIABLES, TRENDS, AND SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Germany Legal Cannabis Market - Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Germany Legal Cannabis: Market Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTLE Analysis
3.4. Current Market Trends in Cannabis Industry
3.5. Regulatory Scenario
3.6. Cannabis Consumption Pattern Analysis
3.7. Guidelines and Requirements for Cannabis Cultivation
3.8. Cannabis Facility Design and Equipment Requirements
3.9. Reimbursement Policies in the Germany
CHAPTER 4. GERMANY LEGAL CANNABIS MARKET: SEGMENT ANALYSIS, BY SOURCE, 2018 - 2030 (USD MILLION)
4.1. Definition and Scope
4.2. Source Market Share Analysis, 2024 & 2030
4.3. Segment Dashboard
4.4. Germany Legal Cannabis Market, by Source, 2018 to 2030
4.5. Marijuana
4.5.1. Marijuana Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. Flower
4.5.2.1. Flower Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3. Oil and Tinctures
4.5.3.1. Oil and Tinctures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Hemp
4.6.1. Hemp Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.2. Hemp Oil
4.6.2.1. Hemp Oil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.3. Industrial Hemp
4.6.3.1. Industrial Hemp Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. GERMANY LEGAL CANNABIS MARKET: SEGMENT ANALYSIS, BY DERIVATIVE, 2018 - 2030 (USD MILLION)
5.1. Definition and Scope
5.2. Derivative Market Share Analysis, 2024 & 2030
5.3. Segment Dashboard
5.4. Germany Legal Cannabis Market, by Derivative, 2018 to 2030
5.5. CBD
5.5.1. CBD Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. THC
5.6.1. THC Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. GERMANY LEGAL CANNABIS MARKET: SEGMENT ANALYSIS, BY END USE, 2018 - 2030 (USD MILLION)
6.1. Definition and Scope
6.2. End Use Market Share Analysis, 2024 & 2030
6.3. Segment Dashboard
6.4. Germany Legal Cannabis Market, by End Use, 2018 to 2030
6.5. Medical Use
6.5.1. Medical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Cancer
6.5.2.1. Cancer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Chronic Pain
6.5.3.1. Chronic Pain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.4. Depression and Anxiety
6.5.4.1. Depression and Anxiety Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.5. Arthritis
6.5.5.1. Arthritis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.6. Diabetes
6.5.6.1. Diabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.7. Glaucoma
6.5.7.1. Glaucoma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.8. Migraines
6.5.8.1. Migraines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.9. Epilepsy
6.5.9.1. Epilepsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.10. Multiple Sclerosis
6.5.10.1. Multiple Sclerosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.11. AIDS
6.5.11.1. AIDS Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.12. Amyotrophic Lateral Sclerosis
6.5.12.1. Amyotrophic Lateral Sclerosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.13. Alzheimers's
6.5.13.1. Alzheimers's Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.14. Post Traumatic Stress Disorder (PTSD)
6.5.14.1. Post Traumatic Stress Disorder (PTSD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.15. Parkinson's
6.5.15.1. Parkinson's Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.16. Tourettes
6.5.16.1. Tourettes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.17. Others
6.5.17.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Recreational Use
6.6.1. Recreational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Industrial Use
6.7.1. Industrial Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. GERMANY LEGAL CANNABIS MARKET: COMPETITIVE LANDSCAPE
7.1. Participant’s Categorization
7.2. Company Market Position Analysis, 2024
7.3. Strategy Mapping
7.4. Company Profiles
7.4.1. The Cronos Group
7.4.1.1. Overview
7.4.1.2. Financial Performance
7.4.1.3. Service Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. Organigram Holding, Inc.
7.4.2.1. Overview
7.4.2.2. Financial Performance
7.4.2.3. Service Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Tilray Brands
7.4.3.1. Overview
7.4.3.2. Financial Performance
7.4.3.3. Service Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. Canopy Growth Corporation
7.4.4.1. Overview
7.4.4.2. Financial Performance
7.4.4.3. Service Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. Aurora Cannabis
7.4.5.1. Overview
7.4.5.2. Financial Performance
7.4.5.3. Service Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. SynBiotic
7.4.6.1. Overview
7.4.6.2. Financial Performance
7.4.6.3. Service Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. Cansativa GmbH
7.4.7.1. Overview
7.4.7.2. Financial Performance
7.4.7.3. Service Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. DEMECAN
7.4.8.1. Overview
7.4.8.2. Financial Performance
7.4.8.3. Service Benchmarking
7.4.8.4. Strategic Initiatives
7.4.9. Four 20 Pharma
7.4.9.1. Overview
7.4.9.2. Financial Performance
7.4.9.3. Service Benchmarking
7.4.9.4. Strategic Initiatives
7.4.10. Avextra Pharma GmbH
7.4.10.1. Overview
7.4.10.2. Financial Performance
7.4.10.3. Service Benchmarking
7.4.10.4. Strategic Initiatives
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Source outlook
2.2.2. Derivatives outlook
2.2.3. End Use outlook
2.3. Competitive Insights
CHAPTER 3. GERMANY LEGAL CANNABIS MARKET VARIABLES, TRENDS, AND SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Germany Legal Cannabis Market - Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Germany Legal Cannabis: Market Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTLE Analysis
3.4. Current Market Trends in Cannabis Industry
3.5. Regulatory Scenario
3.6. Cannabis Consumption Pattern Analysis
3.7. Guidelines and Requirements for Cannabis Cultivation
3.8. Cannabis Facility Design and Equipment Requirements
3.9. Reimbursement Policies in the Germany
CHAPTER 4. GERMANY LEGAL CANNABIS MARKET: SEGMENT ANALYSIS, BY SOURCE, 2018 - 2030 (USD MILLION)
4.1. Definition and Scope
4.2. Source Market Share Analysis, 2024 & 2030
4.3. Segment Dashboard
4.4. Germany Legal Cannabis Market, by Source, 2018 to 2030
4.5. Marijuana
4.5.1. Marijuana Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. Flower
4.5.2.1. Flower Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3. Oil and Tinctures
4.5.3.1. Oil and Tinctures Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Hemp
4.6.1. Hemp Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.2. Hemp Oil
4.6.2.1. Hemp Oil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.3. Industrial Hemp
4.6.3.1. Industrial Hemp Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. GERMANY LEGAL CANNABIS MARKET: SEGMENT ANALYSIS, BY DERIVATIVE, 2018 - 2030 (USD MILLION)
5.1. Definition and Scope
5.2. Derivative Market Share Analysis, 2024 & 2030
5.3. Segment Dashboard
5.4. Germany Legal Cannabis Market, by Derivative, 2018 to 2030
5.5. CBD
5.5.1. CBD Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. THC
5.6.1. THC Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. GERMANY LEGAL CANNABIS MARKET: SEGMENT ANALYSIS, BY END USE, 2018 - 2030 (USD MILLION)
6.1. Definition and Scope
6.2. End Use Market Share Analysis, 2024 & 2030
6.3. Segment Dashboard
6.4. Germany Legal Cannabis Market, by End Use, 2018 to 2030
6.5. Medical Use
6.5.1. Medical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Cancer
6.5.2.1. Cancer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Chronic Pain
6.5.3.1. Chronic Pain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.4. Depression and Anxiety
6.5.4.1. Depression and Anxiety Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.5. Arthritis
6.5.5.1. Arthritis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.6. Diabetes
6.5.6.1. Diabetes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.7. Glaucoma
6.5.7.1. Glaucoma Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.8. Migraines
6.5.8.1. Migraines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.9. Epilepsy
6.5.9.1. Epilepsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.10. Multiple Sclerosis
6.5.10.1. Multiple Sclerosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.11. AIDS
6.5.11.1. AIDS Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.12. Amyotrophic Lateral Sclerosis
6.5.12.1. Amyotrophic Lateral Sclerosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.13. Alzheimers's
6.5.13.1. Alzheimers's Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.14. Post Traumatic Stress Disorder (PTSD)
6.5.14.1. Post Traumatic Stress Disorder (PTSD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.15. Parkinson's
6.5.15.1. Parkinson's Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.16. Tourettes
6.5.16.1. Tourettes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.17. Others
6.5.17.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Recreational Use
6.6.1. Recreational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Industrial Use
6.7.1. Industrial Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. GERMANY LEGAL CANNABIS MARKET: COMPETITIVE LANDSCAPE
7.1. Participant’s Categorization
7.2. Company Market Position Analysis, 2024
7.3. Strategy Mapping
7.4. Company Profiles
7.4.1. The Cronos Group
7.4.1.1. Overview
7.4.1.2. Financial Performance
7.4.1.3. Service Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. Organigram Holding, Inc.
7.4.2.1. Overview
7.4.2.2. Financial Performance
7.4.2.3. Service Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Tilray Brands
7.4.3.1. Overview
7.4.3.2. Financial Performance
7.4.3.3. Service Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. Canopy Growth Corporation
7.4.4.1. Overview
7.4.4.2. Financial Performance
7.4.4.3. Service Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. Aurora Cannabis
7.4.5.1. Overview
7.4.5.2. Financial Performance
7.4.5.3. Service Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. SynBiotic
7.4.6.1. Overview
7.4.6.2. Financial Performance
7.4.6.3. Service Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. Cansativa GmbH
7.4.7.1. Overview
7.4.7.2. Financial Performance
7.4.7.3. Service Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. DEMECAN
7.4.8.1. Overview
7.4.8.2. Financial Performance
7.4.8.3. Service Benchmarking
7.4.8.4. Strategic Initiatives
7.4.9. Four 20 Pharma
7.4.9.1. Overview
7.4.9.2. Financial Performance
7.4.9.3. Service Benchmarking
7.4.9.4. Strategic Initiatives
7.4.10. Avextra Pharma GmbH
7.4.10.1. Overview
7.4.10.2. Financial Performance
7.4.10.3. Service Benchmarking
7.4.10.4. Strategic Initiatives
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Germany legal cannabis market, by source, 2018 - 2030 (USD Million)
Table 4 Germany legal cannabis market, by derivatives, 2018 - 2030 (USD Million)
Table 5 Germany legal cannabis market, by end use, 2018 - 2030 (USD Million)
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Germany legal cannabis market, by source, 2018 - 2030 (USD Million)
Table 4 Germany legal cannabis market, by derivatives, 2018 - 2030 (USD Million)
Table 5 Germany legal cannabis market, by end use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Value-chain-based sizing & forecasting
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market research approaches
Fig. 7 Market formulation & validation
Fig. 8 Germany legal cannabis market: market outlook
Fig. 9 Germany legal cannabis competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook.
Fig. 12 Industry value chain analysis
Fig. 13 Germany legal cannabis market driver impact
Fig. 14 Germany legal cannabis market restraint impact
Fig. 15 Germany legal cannabis market strategic initiatives analysis
Fig. 16 Germany legal cannabis market: Source movement analysis
Fig. 17 Germany legal cannabis market: Source outlook and key takeaways
Fig. 18 Hemp market estimates and forecasts, 2018 - 2030
Fig. 19 Hemp Oil market estimates and forecasts, 2018 - 2030
Fig. 20 Industrial Hemp market estimates and forecasts, 2018 - 2030
Fig. 21 Marijuana market estimates and forecasts, 2018 - 2030
Fig. 22 Flower market estimates and forecasts, 2018 - 2030
Fig. 23 Oil and Tinctures market estimates and forecasts, 2018 - 2030
Fig. 24 Germany legal cannabis market: Derivatives movement analysis
Fig. 25 Germany legal cannabis market: Derivatives outlook and key takeaways
Fig. 26 CBD market estimates and forecasts, 2018 - 2030
Fig. 27 THC market estimates and forecasts, 2018 - 2030
Fig. 28 Others market estimates and forecasts, 2018 - 2030
Fig. 29 Germany legal cannabis market: End-use movement analysis
Fig. 30 Germany legal cannabis market: End-use outlook and key takeaways
Fig. 31 Industrial Use market estimates and forecasts, 2018 - 2030
Fig. 32 Medical Use market estimates and forecasts, 2018 - 2030
Fig. 33 Chronic Pain market estimates and forecasts, 2018 - 2030
Fig. 34 Depression and Anxiety market estimates and forecasts, 2018 - 2030
Fig. 35 Arthritis market estimates and forecasts, 2018 - 2030
Fig. 36 Post Traumatic Stress Disorder (PTSD) market estimates and forecasts, 2018 - 2030
Fig. 37 Cancer market estimates and forecasts, 2018 - 2030
Fig. 38 Migraines market estimates and forecasts, 2018 - 2030
Fig. 39 Epilepsy market estimates and forecasts, 2018 - 2030
Fig. 40 Alzheimers's market estimates and forecasts, 2018 - 2030
Fig. 41 Multiple Sclerosis market estimates and forecasts, 2018 - 2030
Fig. 42 AIDS market estimates and forecasts, 2018 - 2030
Fig. 43 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2018 - 2030
Fig. 44 Tourettes market estimates and forecasts, 2018 - 2030
Fig. 45 Diabetes market estimates and forecasts, 2018 - 2030
Fig. 46 Parkinson's market estimates and forecasts, 2018 - 2030
Fig. 47 Glaucoma market estimates and forecasts, 2018 - 2030
Fig. 48 Others market estimates and forecasts, 2018 - 2030
Fig. 49 Recreational Use market estimates and forecasts, 2018 - 2030
Fig. 50 Key company categorization
Fig. 51 Heatmap analysis, 2024
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Value-chain-based sizing & forecasting
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market research approaches
Fig. 7 Market formulation & validation
Fig. 8 Germany legal cannabis market: market outlook
Fig. 9 Germany legal cannabis competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook.
Fig. 12 Industry value chain analysis
Fig. 13 Germany legal cannabis market driver impact
Fig. 14 Germany legal cannabis market restraint impact
Fig. 15 Germany legal cannabis market strategic initiatives analysis
Fig. 16 Germany legal cannabis market: Source movement analysis
Fig. 17 Germany legal cannabis market: Source outlook and key takeaways
Fig. 18 Hemp market estimates and forecasts, 2018 - 2030
Fig. 19 Hemp Oil market estimates and forecasts, 2018 - 2030
Fig. 20 Industrial Hemp market estimates and forecasts, 2018 - 2030
Fig. 21 Marijuana market estimates and forecasts, 2018 - 2030
Fig. 22 Flower market estimates and forecasts, 2018 - 2030
Fig. 23 Oil and Tinctures market estimates and forecasts, 2018 - 2030
Fig. 24 Germany legal cannabis market: Derivatives movement analysis
Fig. 25 Germany legal cannabis market: Derivatives outlook and key takeaways
Fig. 26 CBD market estimates and forecasts, 2018 - 2030
Fig. 27 THC market estimates and forecasts, 2018 - 2030
Fig. 28 Others market estimates and forecasts, 2018 - 2030
Fig. 29 Germany legal cannabis market: End-use movement analysis
Fig. 30 Germany legal cannabis market: End-use outlook and key takeaways
Fig. 31 Industrial Use market estimates and forecasts, 2018 - 2030
Fig. 32 Medical Use market estimates and forecasts, 2018 - 2030
Fig. 33 Chronic Pain market estimates and forecasts, 2018 - 2030
Fig. 34 Depression and Anxiety market estimates and forecasts, 2018 - 2030
Fig. 35 Arthritis market estimates and forecasts, 2018 - 2030
Fig. 36 Post Traumatic Stress Disorder (PTSD) market estimates and forecasts, 2018 - 2030
Fig. 37 Cancer market estimates and forecasts, 2018 - 2030
Fig. 38 Migraines market estimates and forecasts, 2018 - 2030
Fig. 39 Epilepsy market estimates and forecasts, 2018 - 2030
Fig. 40 Alzheimers's market estimates and forecasts, 2018 - 2030
Fig. 41 Multiple Sclerosis market estimates and forecasts, 2018 - 2030
Fig. 42 AIDS market estimates and forecasts, 2018 - 2030
Fig. 43 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2018 - 2030
Fig. 44 Tourettes market estimates and forecasts, 2018 - 2030
Fig. 45 Diabetes market estimates and forecasts, 2018 - 2030
Fig. 46 Parkinson's market estimates and forecasts, 2018 - 2030
Fig. 47 Glaucoma market estimates and forecasts, 2018 - 2030
Fig. 48 Others market estimates and forecasts, 2018 - 2030
Fig. 49 Recreational Use market estimates and forecasts, 2018 - 2030
Fig. 50 Key company categorization
Fig. 51 Heatmap analysis, 2024
